国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
左卡尼汀联合尼可地尔治疗不稳定型心绞痛疗效观察
Observation of the Effects of Levocarnitine Combined with Nicorandil in the Treatment of Unstable Angina Pectoris
  
DOI:
中文关键词:  左卡尼汀  尼可地尔  联合用药  不稳定型心绞痛
英文关键词:Levocarnitine  Nicorandil  Drug combination  Unstable angina pectoris
基金项目:
作者单位
刘敏 江汉大学附属武汉市第六医院(武汉 430016) 
杨明 江汉大学附属武汉市第六医院 
于洋 江汉大学附属武汉市第六医院 
程波 江汉大学附属武汉市第六医院 
朱磊 江汉大学附属武汉市第六医院 
张苏川 江汉大学附属武汉市第六医院 
摘要点击次数: 1129
全文下载次数: 1394
中文摘要:
      摘 要 目的:评价左卡尼汀注射液联合尼可地尔片治疗不稳定型心绞痛的效果。方法:120例不稳定型心绞痛患者随机分为对照组、尼可地尔组、联合治疗组各40例。三组均给予冠心病常规治疗,尼可地尔组在此基础上加用尼可地尔片5 mg,po tid,持续30 d;联合治疗组在尼可地尔组治疗基础上再加用左卡尼汀注射液20 mg·kg-1·d-1, ivd,连用14 d。三组观察期均为30 d。比较三组患者治疗前后各项血脂指标、左室舒张末期内径及左射血分数、心绞痛症状缓解情况、心电图的变化及主要心脏不良事件和药品不良反应。结果:与尼可地尔组及对照组比较,联合治疗组可明显改善心绞痛症状并显著减少主要心脏不良事件(P<0.05);联合治疗组的TC、LDL、TG等低于其他两组(P<0.05)。联合治疗组与尼可地尔组在改善心绞痛程度和心血管事件发生率方面均优于对照组(P<0.05)。 结论:左卡尼汀注射液联合尼可地尔片治疗不稳定型心绞痛,可显著提高临床总有效率且较安全可靠,为临床医生治疗不稳定性心绞痛提供了新的思路。
英文摘要:
      ABSTRACT Objective:To study on the therapeutic effect of levocarnitine injection combined with nicorandil tablets on patients with unstable angina pectoris.Methods:120 patients with unstable angina were randomly divided into three groups, 40 cases in the control group, nicorandil group 40 cases, nicorandil combined levocarnitine group 40 cases. The three groups were given conventional treatment of coronary heart disease, nicorandil group and routine treatment for oral nicorandil tablets 5mg tid, period of treatment was 30 days. Nicorandil combined levocarnitine group in addition to conventional treatment, treated with nicorandil tablets orally 5mg tid, period of treatment was 30 days, while addition of levocarnitine injection 20 mg·kg-1·d-1 intravenously for 14 days, the three groups were observed for 30 days. Blood lipid parameter, left ventricular end diastolic diameter and left ejection fraction, relieving angina pectoris symptom changes of electrocardiogram, adverse drug reactions and major adverse cardiac events were compared before and after the treatment.Results:Compared with the control group and nicorandil group, combined treatment group can significantly improve the symptoms of angina pectoris and significantly reduce the incidence of major adverse cardiac events(P<0.05). The TC,LDL,TG of combination therapy group were below the other two groups and HDL was higher than the other two groups (P<0.05). To improve the degree of angina pectoris combined treatment group and nicorandil group was better than the control group (P<0.05). The occurrence rate of cardiovascular event in combined treatment group and nicorandil group were lower than control group(P<0.05). Conclusion:Levocarnitine injection combined nicorandil tablets in treatment of unstable angina pectoris, could significantly improve the clinical total effective rate and was safe and reliable. It provideed a new idea for clinicians treating unstable angina pectoris.
查看全文  查看/发表评论  下载PDF阅读器
关闭